Scientists created human pancreas on a chip that allowed them to identify the possible cause of a frequent and deadly complication of cystic fibrosis (CF) called CF-Related Diabetes, or CFRD.
It may be feasible to also use the small two-chambered device, which features bioengineered human pancreatic organoids to study the causes of non-CF-related conditions such as type 1 and 2 diabetes, according to researchers who report findings in Nature Communications.
First, however, the scientists want to see if their device can help people with CF--a genetic lung disease caused by a mutation in the CFTR gene. The mutation leads to a water and salt imbalance on cell surfaces that clogs the lungs with thick mucus.
As people with CF get older, they become increasingly at risk for CFRD, according to the study's principal investigator. Making matters worse is that until now there hasn't been an effective way to study CFRD in the lab to look for better treatments.
"Mouse models of CF don't faithfully recreate CF-Related Diabetes in the lab, and it wasn't possible to study the disease at the depth we achieved in this study," said the senior author. "Our technology closely resembles the human pancreas and potentially may help us find therapeutic measures to manage glucose imbalance in people with CF, which is linked to increased illness and death."
The in vitro chip technology can be used to study CFRD and glucose imbalance in specific individuals with the condition, creating the potential for diagnosing different disease manifestations on a highly personalized basis. The chip can help assay variability in the glucose measures of different people, determine correlation of glucose levels with the CFTR mutation type, and test small-molecule interventions.
Although mutations in the CFTR gene are known to cause cystic fibrosis, its role in CFRD is unclear. To answer that question, the researchers started by isolating pancreatic ductal epithelial cells and pancreatic islets donated by surgical patients.
The ductal organoids were cultured in a transparent dual-chamber called a microfluidic device, which contained specific biochemical solutions to generate the pancreas-on-a-chip. Ductal epithelial cells were cultured in the top chamber and pancreatic islet cells were in the bottom chamber, separated by a thin layer of porous membrane that allowed the different chambers to interact.
The cells grew and expanded into three-dimensional pancreatic organs that mimicked cell-to-cell communications and fluid exchange, similar to the function of a naturally developed human pancreas.
When the researchers tested pancreas-on-a-chip by disrupting CFTR gene expression, it impaired cell-to cell communication, fluid exchange and negatively affected endocrine function. This caused an insulin deficiency and recreated the CFRD disease process similar to that observed in the pancreas of a person, Researchers said this confirmed that the CFTR gene has a direct role in regulating insulin secretion and causing diabetes in people with CF.
Microfluidic devices have existed since 1979. But innovations in their design and functionality, especially since the advent of organoid technology, now allow researchers to bioengineer human organ tissues and mimic the function of natural organs in a laboratory setting.
https://www.cincinnatichildrens.org/news/release/2019/pancreas-chip
https://www.nature.com/articles/s41467-019-11178-w
Edited
Latest News
A trial HIV vaccine trigger…
By newseditor
Posted 19 May
AI to predict DNA methylati…
By newseditor
Posted 19 May
Hyperactive platelets from…
By newseditor
Posted 19 May
Chromatin and RNA interacti…
By newseditor
Posted 18 May
Why patients with ARID1A mu…
By newseditor
Posted 18 May
Other Top Stories
Obese inducing brain mechanism
Read more
Trigger for fatty liver in obesity
Read more
Exosomes are the missing link to insulin resistance in diabetes
Read more
Interaction between nerve and immune cells in belly fat accumulation!
Read more
The source of diabetic pain uncovered!
Read more
Protocols
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Mime-seq 2.0: a method to s…
By newseditor
Posted 13 May
Improved detection of DNA r…
By newseditor
Posted 09 May
Single-cell adhesive profil…
By newseditor
Posted 07 May
Publications
Vaccine induction of hetero…
By newseditor
Posted 19 May
Brain border-associated mac…
By newseditor
Posted 19 May
Inhibition of fatty acid up…
By newseditor
Posted 19 May
A microglial activation cas…
By newseditor
Posted 19 May
An age-progressive platelet…
By newseditor
Posted 19 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar